Dr Cassandra Wannan
Research Fellow in Psychosis Risk Research
Centre for Youth Mental Health (Orygen)
70 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
Age-dependent associations between plasma neurofilament light chain protein and symptom severity in treatment-resistant Schizophrenia: a moderation analysis
DOI: 10.1016/j.ejpsy.2026.1003622026
Journal article
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for Psychosis
DOI: 10.1111/eip.701832026
Journal article
Preserved white matter structure at the grey matter-white matter interface despite widespread cortical thinning in early psychosis.
DOI: 10.1016/j.bpsc.2026.05.0152026
Journal article
Exploring the interconnections between baseline symptoms in ultra-high risk youth who did and did not transition to psychosis over three years: A network analysis comparison
DOI: 10.1192/j.eurpsy.2025.101412025
Research grants (ARC, NHMRC, MRFF)
Multi-Axial Profile Scores (MAPS): A Personalised Fingerprinting Framework for Improving Diagnosis and Treatment of Psychiatric Disorders
2023
Research Contracts
Multivariate Brain Structure-Cognition Signatures of Early Psychosis
2022
Internal Research Grant
Biopsychosocial Markers of Childhood Schizotypy: Improving Diagnosis and Predicting Outcomes
RECENT SCHOLARLY WORKS
2026
Journal article
Cognitive correlates of brain metabolites measured by MRS along the psychosis continuum: systematic review
DOI: 10.1016/j.nsa.2025.1057972026
Journal article
Relationship among Sleep Disturbance, Stress, and Suicidal Ideation in Clinical High Risk for Psychosis.
DOI: 10.1093/schizbullopen/sgag0242025
Journal article
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
DOI: 10.1038/s41537-025-00581-62025
Journal article
Temperament mediates the relationship between family environment and psychotic-like experiences in early adolescence: Findings from the ABCD study
DOI: 10.1016/j.schres.2025.10.0142025
Journal article
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations
DOI: 10.1038/s41537-025-00610-42025
Journal article
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk Individuals
DOI: 10.1093/schbul/sbae204